According to Compugen's latest financial reports and stock price the company's current number of shares outstanding is 89,505,618. At the end of 2024 the company had 89,505,618 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 89.5 M | 1.35% |
2023 | 88.31 M | 1.95% |
2022 | 86.62 M | 1.48% |
2021 | 85.35 M | 2.05% |
2020 | 83.64 M | 23.65% |
2019 | 67.64 M | 13.61% |
2018 | 59.54 M | 16.09% |
2017 | 51.29 M | 0.48% |
2016 | 51.04 M | 1.03% |
2015 | 50.52 M | 0.76% |
2014 | 50.14 M | 22.89% |
2013 | 40.8 M | 12.95% |
2012 | 36.12 M | 5.27% |
2011 | 34.31 M | 3.02% |
2010 | 33.31 M | 16.66% |
2009 | 28.55 M | 0.25% |
2008 | 28.48 M | 0.64% |
2007 | 28.29 M | 1.18% |
2006 | 27.96 M | 0.68% |
2005 | 27.77 M | 0.84% |
2004 | 27.54 M | 4.06% |
2003 | 26.47 M | 1.35% |
2002 | 26.12 M | 0.46% |
2001 | 26 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Seagen
SGEN | 188,135,000 | 110.19% | ๐บ๐ธ USA |
Genetic Technologies GENE | 129,424 | -99.86% | ๐ฆ๐บ Australia |
Teva Pharmaceutical Industries TEVA | 1,123,000,000 | 1,154.67% | ๐ฎ๐ฑ Israel |
Eterna Therapeutics ERNA | 5,410,000 | -93.96% | ๐บ๐ธ USA |